Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges

por Han, Ethan Q, Li, Xiu-ling, Wang, Chun-rong, Li, Tian-fang, Han, Shuang-yin
Publicado 2013

Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma

por Shen, Chan-Juan, Yang, Yu-Xiu, Han, Ethan Q, Cao, Na, Wang, Yun-Fei, Wang, Yi, Zhao, Ying-Ying, Zhao, Li-Ming, Cui, Jian, Gupta, Puja, Wong, Albert J, Han, Shuang-Yin
Publicado 2013